The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(ethylsulfonyl)phenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)benzo[b]thiophen-6-ol ID: ALA395291
PubChem CID: 44427405
Max Phase: Preclinical
Molecular Formula: C29H31NO5S2
Molecular Weight: 537.70
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCS(=O)(=O)c1ccc(-c2sc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1
Standard InChI: InChI=1S/C29H31NO5S2/c1-2-37(32,33)25-13-6-21(7-14-25)29-28(26-15-8-22(31)20-27(26)36-29)35-24-11-9-23(10-12-24)34-19-18-30-16-4-3-5-17-30/h6-15,20,31H,2-5,16-19H2,1H3
Standard InChI Key: QQOLSZOGLJIRPW-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
11.9420 -1.1040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9406 -1.9313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6533 -2.3441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6514 -0.6915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3691 -1.1001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3697 -1.9313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1604 -2.1877 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.6486 -1.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1596 -0.8428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4692 -1.5140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8814 -2.2295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7053 -2.2294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1179 -1.5144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7007 -0.7981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8782 -0.8019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2259 -2.3426 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4133 -0.0584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9666 0.6348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3454 1.3683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8994 2.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0749 2.0212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6983 1.2828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1465 0.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6273 2.7138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8036 2.6725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3561 3.3651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5325 3.3237 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0810 4.0176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2609 3.9785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8809 3.2462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3274 2.5518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1538 2.5896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9426 -1.5127 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.7651 -1.5118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9414 -0.6881 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9460 -2.3374 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1781 -2.2255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 8 1 0
17 18 1 0
8 9 2 0
18 19 2 0
9 5 1 0
19 20 1 0
4 1 1 0
20 21 2 0
5 6 1 0
21 22 1 0
10 11 2 0
22 23 2 0
23 18 1 0
21 24 1 0
11 12 1 0
24 25 1 0
2 3 1 0
25 26 1 0
12 13 2 0
26 27 1 0
27 28 1 0
3 6 2 0
13 14 1 0
1 2 2 0
14 15 2 0
15 10 1 0
27 32 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
8 10 1 0
13 33 1 0
5 4 2 0
33 34 1 0
2 16 1 0
33 35 2 0
6 7 1 0
33 36 2 0
9 17 1 0
34 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 537.70Molecular Weight (Monoisotopic): 537.1644AlogP: 6.72#Rotatable Bonds: 9Polar Surface Area: 76.07Molecular Species: BASEHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.47CX Basic pKa: 8.68CX LogP: 5.40CX LogD: 4.36Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.26Np Likeness Score: -1.02
References 1. Richardson TI, Frank SA, Wang M, Clarke CA, Jones SA, Ying BP, Kohlman DT, Wallace OB, Shepherd TA, Dally RD, Palkowitz AD, Geiser AG, Bryant HU, Henck JW, Cohen IR, Rudmann DG, McCann DJ, Coutant DE, Oldham SW, Hummel CW, Fong KC, Hinklin R, Lewis G, Tian H, Dodge JA.. (2007) Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety., 17 (13): [PMID:17482463 ] [10.1016/j.bmcl.2007.04.044 ]